Table 6.

Customized treatment of non-small cell lung cancer based on epidermal growth factor receptor mutations and BRCA1 mRNA expression. Correlation of BRCA1 and RAP80 expression with median survival. Purple circle, cisplatin–gemcitabine; green circle, cisplatin–docetaxel; red, docetaxel monotherapy. Data from Rosell et al. [2007].

		RAP80 mRNA
		Low	Intermediate	High
BRCA1 mRN	Low	NR	8 m	7 m
	Intermediate	5 m	13 m	16 m
	High	6 m	12 m	11 m

m, months.